INFERJECT

This brand name is authorized in Turkey.

Active ingredients

The drug INFERJECT contains one active pharmaceutical ingredient (API):

`1`	Ferric carboxymaltose UNII `6897GXD6OE` - FERRIC CARBOXYMALTOSE
	The iron complex ferric carboxymaltose is designed to provide, in a controlled way, utilisable iron for the iron transport and storage proteins in the body (transferrin and ferritin, respectively). Ferric carboxymaltose treatment results in an increase in reticulocyte count, serum ferritin levels and TSAT levels to within normal ranges.
	Read more about Ferric carboxymaltose

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
TR	İlaç ve Tıbbi Cihaz Kurumu	8699514750062, 8699514750185, 8699514750239

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.